Immunohistochemistry analysis revealed that lamin-deficient tumor had a comparable STING intensity than the control xenograft (Figures 4K, L), indicating that the STING/TBK1 pathway may not be the downstream mechanism. This evidence concerns the gene STING1 and neoplasm.